Urodynamic Characteristics of Patients with Urge Incontinence treated with Sacral Neuromodulation and Adjunct Botulinum Toxin Injection

Files

Authors

Brent Yelton, Oakland University William Beaumont School of Medicine Student
Jason Gilleran, Beaumont Health

Description

Sacral neuromodulation (SN) and intradetrusor botulinum toxin (BTX) are effective treatments for refractory overactive bladder (OAB) and urge incontinence (UI).1 The decision on which treatment to use is based on several factors. Urodynamics (UDS) have not been proven to determine who will respond to SN. Detrusor overactivity (DO) suggests that BTX may be more effective, given its direct role on muscle. The purpose of this study is to determine if presence and severity of DO on UDS is associated with failure of SN and response to BTX.

Publication Date

5-2023

Keywords

Sacral neuromodulation, intradetrusor botulinum toxin, overactive bladder, urge incontinence, Urodynamics, Detrusor overactivity

Disciplines

Urology

Recommended Citation

Yelton B, Gilleran J. Urodynamic characteristics of patients with urge incontinence treated with sacral neuromodulation and adjunct botulinum toxin injection. Poster presented at: Oakland University William Beaumont School of Medicine Embark Capstone Colloquium; 2023 May; Rochester Hills, MI.

Comments

The Embark Capstone Colloquium at the Oakland University William Beaumont School of Medicine, Rochester Hills, MI, May, 2023.